The company’s suppliers and manufacturing processes are subject to regulatory compliance, including adherence to the Quality System Regulation (QSR). Suppliers may be required to comply with certain aspects of the QSR. The U.S. Food and Drug Administration (FDA) conducts inspections and may issue Form 483 observations, warning letters, or take enforcement actions if violations are identified. The company must comply with FDA regulations concerning labeling, adverse event reporting, and product promotion. Medical device manufacturers are also required to obtain regulatory approvals in various jurisdictions, a process that can be costly and time-consuming. The company follows globally harmonized quality and risk management standards, which are increasingly adopted in the industry. Export controls govern the transfer of sensitive items and technology. Additionally, the company is subject to healthcare laws regulating interactions with healthcare practitioners and officials, including statutes related to anti-kickback, false claims, physician self-referral, and anti-bribery.
Icad Inc's Comment on Supply Chain
The company’s suppliers and manufacturing processes are subject to regulatory compliance, including adherence to the Quality System Regulation (QSR). Suppliers may be required to comply with certain aspects of the QSR. The U.S. Food and Drug Administration (FDA) conducts inspections and may issue Form 483 observations, warning letters, or take enforcement actions if violations are identified. The company must comply with FDA regulations concerning labeling, adverse event reporting, and product promotion. Medical device manufacturers are also required to obtain regulatory approvals in various jurisdictions, a process that can be costly and time-consuming. The company follows globally harmonized quality and risk management standards, which are increasingly adopted in the industry. Export controls govern the transfer of sensitive items and technology. Additionally, the company is subject to healthcare laws regulating interactions with healthcare practitioners and officials, including statutes related to anti-kickback, false claims, physician self-referral, and anti-bribery.
Sources:
Icad Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Icad Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
